awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35906490-123372E6-B664-4F39-A455-089EBFAC1D00
Q35906490-123372E6-B664-4F39-A455-089EBFAC1D00
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35906490-123372E6-B664-4F39-A455-089EBFAC1D00
SGLT-2 Inhibitors: A New Mechanism for Glycemic Control.
P2860
Q35906490-123372E6-B664-4F39-A455-089EBFAC1D00
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35906490-123372E6-B664-4F39-A455-089EBFAC1D00
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7325488fce019b847ded243d73d5ea243d2d73c5
P2860
Multiple-dose pharmacokinetics and pharmacodynamics of sergliflozin etabonate, a novel inhibitor of glucose reabsorption, in healthy overweight and obese subjects: a randomized double-blind study.